191 related articles for article (PubMed ID: 15173889)
21. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
[TBL] [Abstract][Full Text] [Related]
22. Death by neglect as a deletional mechanism of peripheral tolerance.
Bertolino P; Trescol-Biémont MC; Thomas J; Fazekas de St Groth B; Pihlgren M; Marvel J; Rabourdin-Combe C
Int Immunol; 1999 Aug; 11(8):1225-38. PubMed ID: 10421780
[TBL] [Abstract][Full Text] [Related]
23. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
24. The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis.
Walsh PT; O'Connor R
Eur J Immunol; 2000 Apr; 30(4):1010-8. PubMed ID: 10760788
[TBL] [Abstract][Full Text] [Related]
25. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
26. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
27. Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism.
Martin PJ
Blood; 1996 Aug; 88(3):962-9. PubMed ID: 8704255
[TBL] [Abstract][Full Text] [Related]
28. Alloantigenic stimulation bypasses CD28-B7 costimulatory blockade by an interleukin-2-dependent mechanism.
Blazevic V; Pinto LA; Trubey CM; Shearer GM
J Leukoc Biol; 2000 Jun; 67(6):817-24. PubMed ID: 10857854
[TBL] [Abstract][Full Text] [Related]
29. Induction of alloantigen-specific anergy in human peripheral blood mononuclear cells by alloantigen stimulation with co-stimulatory signal blockade.
Davies JK; Barbon CM; Voskertchian AR; Nadler LM; Guinan EC
J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445041
[TBL] [Abstract][Full Text] [Related]
30. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
31. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway.
Ndejembi MP; Teijaro JR; Patke DS; Bingaman AW; Chandok MR; Azimzadeh A; Nadler SG; Farber DL
J Immunol; 2006 Dec; 177(11):7698-706. PubMed ID: 17114440
[TBL] [Abstract][Full Text] [Related]
32. Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival.
Liu D; Badell IR; Ford ML
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321374
[TBL] [Abstract][Full Text] [Related]
33. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS
J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111
[TBL] [Abstract][Full Text] [Related]
34. Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells.
Yu XZ; Albert MH; Anasetti C
J Immunol; 2006 Mar; 176(6):3383-90. PubMed ID: 16517706
[TBL] [Abstract][Full Text] [Related]
35. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
36. Conversion of alloantigen-specific CD8+ T cell anergy to CD8+ T cell priming through in vivo ligation of glucocorticoid-induced TNF receptor.
Kim J; Choi WS; Kang H; Kim HJ; Suh JH; Sakaguchi S; Kwon B
J Immunol; 2006 May; 176(9):5223-31. PubMed ID: 16621987
[TBL] [Abstract][Full Text] [Related]
37. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.
Taylor PA; Noelle RJ; Blazar BR
J Exp Med; 2001 Jun; 193(11):1311-8. PubMed ID: 11390438
[TBL] [Abstract][Full Text] [Related]
38. CD28 ligation costimulates cell death but not maturation of double-positive thymocytes due to defective ERK MAPK signaling.
Graham DB; Bell MP; Huntoon CJ; Griffin MD; Tai X; Singer A; McKean DJ
J Immunol; 2006 Nov; 177(9):6098-107. PubMed ID: 17056536
[TBL] [Abstract][Full Text] [Related]
39. Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses.
Haspot F; Villemain F; Laflamme G; Coulon F; Olive D; Tiollier J; Soulillou JP; Vanhove B
Blood; 2002 Mar; 99(6):2228-34. PubMed ID: 11877302
[TBL] [Abstract][Full Text] [Related]
40. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing.
Zhan Y; Brady JL; Sutherland RM; Lew AM
J Immunol; 2001 Dec; 167(11):6279-85. PubMed ID: 11714791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
